Janus Global Life Sciences C (JFNCX)
42.52 0.80(1.85%) Dec 11
* As of 30-Nov-13
Quotes delayed, except where indicated otherwise. Currency in USD.
- No Headlines available for JFNCX at this time.
|Morningstar Overall Rating:|
|Annual Report Expense Ratio (net):||NaN%|
Performance & Risk
|5y Avg Return:||22.66%|
|Rank in Category (ytd):||31|
|% Rank in Category (ytd):||23.85%|
|Morningstar Risk Rating:||3|
The investment seeks long-term growth of capital.
The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets in securities of companies that the portfolio manager believes have a life science orientation. Generally speaking, the "life sciences" relate to maintaining or improving quality of life. It normally invests at least 25% of its total assets in the "life sciences" sector, which may include companies in the following industry groups: health care; pharmaceuticals; agriculture; cosmetics/personal care; and biotechnology. View More